• Je něco špatně v tomto záznamu ?

Clinical and radiological results of TLIF surgery with titanium-coated PEEK or uncoated PEEK cages: a prospective single-centre randomised study

P. Vanek, N. Svoboda, O. Bradac, J. Malik, R. Kaiser, D. Netuka

. 2024 ; 33 (1) : 332-338. [pub] 20230922

Jazyk angličtina Země Německo

Typ dokumentu randomizované kontrolované studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007830

Grantová podpora
MO 1012 Ministerstvo Obrany České Republiky

E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-02-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do Před 1 rokem

BACKGROUND: A comparison of fusion rates and clinical outcomes of instrumented transforaminal interbody fusion (TLIF) between polyetheretherketone (PEEK) and titanium-coated PEEK (Ti-PEEK) cages is not well documented. METHODS: A single-centre, prospective, randomised study included patients who underwent one-level TLIF between L3-S1 segments. Patients were randomised into one of two groups: TLIF surgery with the PEEK cage and TLIF surgery with the Ti-PEEK cage. Clinical results were measured. All patients were assessed by repeated X-rays and 3D CT scans. Cage integration was assessed using a modified Bridwell classification. The impact of obesity and smoking on fusion quality was also analysed. Patients in both groups were followed up for 2 years. RESULTS: Altogether 87 patients were included in the study: of these 87 patients, 81 (93.1%) completed the 2-year follow-up. A significant improvement in clinical outcome was found in the two measurements scales in both groups (RM: p = 0.257, VAS: p = 0.229). There was an increase in CobbS and CobbL angle in both groups (p = 0.172 for CobbS and p = 0.403for CobbL). Bony fusion was achieved in 37 of 40 (92.5%) patients in the TiPEEK group and 35 of 41 (85.4%) in the PEEK group (p = 0.157). Cage subsided in 2 of 40 patients (5%) in the TiPEEK group and 11 of 41 (26.8%) in the PEEK group (p = 0.007). Body mass index > 30 and smoking were not predictive factors of bony fusion achievement. CONCLUSION: There is no significant advantage of TiPEEK cages over PEEK cages in clinical outcome and fusion rate 2 years after surgery.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007830
003      
CZ-PrNML
005      
20240423160316.0
007      
ta
008      
240412s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00586-023-07947-3 $2 doi
035    __
$a (PubMed)37737497
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Vanek, P $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic
245    10
$a Clinical and radiological results of TLIF surgery with titanium-coated PEEK or uncoated PEEK cages: a prospective single-centre randomised study / $c P. Vanek, N. Svoboda, O. Bradac, J. Malik, R. Kaiser, D. Netuka
520    9_
$a BACKGROUND: A comparison of fusion rates and clinical outcomes of instrumented transforaminal interbody fusion (TLIF) between polyetheretherketone (PEEK) and titanium-coated PEEK (Ti-PEEK) cages is not well documented. METHODS: A single-centre, prospective, randomised study included patients who underwent one-level TLIF between L3-S1 segments. Patients were randomised into one of two groups: TLIF surgery with the PEEK cage and TLIF surgery with the Ti-PEEK cage. Clinical results were measured. All patients were assessed by repeated X-rays and 3D CT scans. Cage integration was assessed using a modified Bridwell classification. The impact of obesity and smoking on fusion quality was also analysed. Patients in both groups were followed up for 2 years. RESULTS: Altogether 87 patients were included in the study: of these 87 patients, 81 (93.1%) completed the 2-year follow-up. A significant improvement in clinical outcome was found in the two measurements scales in both groups (RM: p = 0.257, VAS: p = 0.229). There was an increase in CobbS and CobbL angle in both groups (p = 0.172 for CobbS and p = 0.403for CobbL). Bony fusion was achieved in 37 of 40 (92.5%) patients in the TiPEEK group and 35 of 41 (85.4%) in the PEEK group (p = 0.157). Cage subsided in 2 of 40 patients (5%) in the TiPEEK group and 11 of 41 (26.8%) in the PEEK group (p = 0.007). Body mass index > 30 and smoking were not predictive factors of bony fusion achievement. CONCLUSION: There is no significant advantage of TiPEEK cages over PEEK cages in clinical outcome and fusion rate 2 years after surgery.
650    _2
$a lidé $7 D006801
650    12
$a titan $7 D014025
650    _2
$a bederní obratle $x chirurgie $7 D008159
650    _2
$a prospektivní studie $7 D011446
650    12
$a fúze páteře $x metody $7 D013123
650    _2
$a polyethylenglykoly $7 D011092
650    _2
$a ketony $7 D007659
650    _2
$a výsledek terapie $7 D016896
650    12
$a benzofenony $7 D001577
650    12
$a polymery $7 D011108
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a časopisecké články $7 D016428
700    1_
$a Svoboda, N $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic. svoboda.norbert@gmail.com $1 https://orcid.org/0000000176894862
700    1_
$a Bradac, O $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic
700    1_
$a Malik, J $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic
700    1_
$a Kaiser, R $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic
700    1_
$a Netuka, D $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and Military University Hospital Prague, U Vojenskénemocnice 1200/2, 16000, Prague 6, Czech Republic
773    0_
$w MED00001666 $t European spine journal $x 1432-0932 $g Roč. 33, č. 1 (2024), s. 332-338
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37737497 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423160312 $b ABA008
999    __
$a ok $b bmc $g 2081684 $s 1217597
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 33 $c 1 $d 332-338 $e 20230922 $i 1432-0932 $m European spine journal $n Eur Spine J $x MED00001666
GRA    __
$a MO 1012 $p Ministerstvo Obrany České Republiky
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...